Skip to contentI
INSMED Inc
I
INSMINSMED Inc Source filing unavailable
Q2 2013 · —
Revenue$11.50M$11.50M— vs Q2 2012 Net Income-$8.85M-$8.85MN/M vs Q2 2012 EPS Diluted-$0.28-$0.28N/M vs Q2 2012 Operating Income-$8,270,000N/M Operating Cash Flowderived-$5,112,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Free Cash Flowderived
Margins · derivedOperating margin-71.9%
Net margin-77.0%